Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

A Phase II Study of Curcumin and Vitamin D in Previously Untreated Patients with Early Stage Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL)

Basem M. William, MRCP, MD, Kaylee Brillhart, Manuel Afable, MD, Kristen Bakalarz, CNP, Brenda Cooper, MD, Hillard M Lazarus, MD, Stanton L. Gerson, MD, Richard Creger, PharmD, Kalyanam Nagabhushanam, PhD, James Grote, MD, Pingfu Fu, Sandeep Kunati, PhD, Shuming Yang, PhD, Yan Xu, PhD, Philip Woost, PhD, James Jacobberger, PhD, Marcos de Lima, MD, Paolo Caimi, MD

Blood (2018) 132 (Supplement 1): 1875.

https://doi.org/10.1182/blood-2018-99-112295

Published: 2018

Journal Articles

Phase I Trial of the Base – Excision Repair Blocker Methoxyamine (TRC-102) Combined with Fludarabine in Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) and Lymphoid Malignancies

Paolo Caimi, MD, Brenda Cooper, MD, Basem M. William, MD, Erica L Campagnaro, MD, Richard J. Creger, Pharm D, Manuel Afable, BSN, MD, Yan Xu, PhD, John Pink, PhD, Afshin Dowlati, Hillard M. Lazarus, MD, Marcos de Lima, MD, Stanton L. Gerson

Blood (2014) 124 (21): 4688.

https://doi.org/10.1182/blood.V124.21.4688.4688

Published: 2014

Journal Articles

Brentuximab Vedotin (BV) Does Not Impair Autologous Peripheral Blood Stem Cell Mobilization and Collection in Refractory/Relapsed CD30+ Lymphoma Patients Undergoing High-Dose Chemotherapy and Autologous Stem Cell Transplant (HDC-ASCT)

Manuel Afable, BSN, MD, Paolo F. Caimi, MD, Chitra Hosing, Marcos de Lima, MD, Issa F. Khouri, MD, Basem M. William, MD, Yago Nieto, MD PhD, Brenda W. Cooper, MD, Paolo Anderlini, MD, Erica L Campagnaro, MD, Stanton L. Gerson, Hillard M. Lazarus, MD, Richard E. Champlin, Uday R. Popat, MD

Blood (2014) 124 (21): 3854.

https://doi.org/10.1182/blood.V124.21.3854.3854

Published: 2014

Journal Articles

Molecular Defects In BRCC3 Complex, a Novel Pathogenic Pathway In MDS

Blood (2013) 122 (21): 264.

https://doi.org/10.1182/blood.V122.21.264.264

Published: 2013

Journal Articles

STAT3 mutations indicate the presence of subclinical T-cell clones in a subset of aplastic anemia and myelodysplastic syndrome patients

Blood (2013) 122 (14): 2453–2459.

https://doi.org/10.1182/blood-2013-04-494930

Published: 2013

Includes: Supplemental data

Journal Articles

Phase 2 study of the lenalidomide and azacitidine combination in patients with higher-risk myelodysplastic syndromes

Mikkael A. Sekeres, Ramon V. Tiu, Rami Komrokji, Jeffrey Lancet, Anjali S. Advani, Manuel Afable, Ricki Englehaupt, Joyce Juersivich, David Cuthbertson, Jennifer Paleveda, Ali Tabarroki, Valeria Visconte, Hideki Makishima, Andres Jerez, Ronald Paquette, Alan F. List, Jaroslaw P. Maciejewski

Blood (2012) 120 (25): 4945–4951.

https://doi.org/10.1182/blood-2012-06-434639

Published: 2012

Includes: Supplemental data

Journal Articles

STAT3 mutations unify the pathogenesis of chronic lymphoproliferative disorders of NK cells and T-cell large granular lymphocyte leukemia

Blood (2012) 120 (15): 3048–3057.

https://doi.org/10.1182/blood-2012-06-435297

Published: 2012

Includes: Supplemental data

Journal Articles

Efficacy of Rabbit Anti-Thymocyte Globulin (ATG) Compared to Horse ATG In Severe Aplastic Anemia

Manuel Afable, II, Mohammed Shaik, MD, Yuka Sugimoto, MD, PhD, Michael Clemente, Ramon V. Tiu, MD, Sanjay R. Mohan, MD, Nelli Bejanyan, Paul Elson, Matt Kalaycio, MD, Anjali Advani, MD, Ronald Sobecks, MD, Alan E. Lichtin, MD, Mikkael A. Sekeres, MD, MS, Jaroslaw Maciejewski

Blood (2010) 116 (21): 2236.

https://doi.org/10.1182/blood.V116.21.2236.2236

Published: 2010

Journal Articles

Deletions of Xp22.2 Including PIG-A Locus Lead to Paroxysmal Nocturnal Hemoglobinuria.

Christine L. O'Keefe, Chiharu Sugimori, Manuel Afable, Michael Clemente, Kenneth Shain, David Araten, Alan F. List, P.K. Epling-Burnette, Jaroslaw Maciejewski

Blood (2010) 116 (21): 1158.

https://doi.org/10.1182/blood.V116.21.1158.1158

Published: 2010

Journal Articles

Cytogenetic Predictors of Response to Lenalidomide In Myeloid Malignancies without Del(5q)

Yuka Sugimoto, MD, PhD, Mikkael A. Sekeres, MD, MS, Hideki Makishima, MD, PhD, Christine L. O'Keefe, PhD, Kathryn Guinta, Manuel Afable, Kathy Rocha McGraw, BS, Alan F. List, Jaroslaw Maciejewski

Blood (2010) 116 (21): 4016.

https://doi.org/10.1182/blood.V116.21.4016.4016

Published: 2010

Journal Articles

GWAS Indicates the Presence of Rare Immunogenetic Polymorphisms as Possible Predisposition Factors in Aplastic Anemia.

Bartlomiej P Przychodzen, Monika Jasek, PhD, Sandra P Smieszek, Ron Paquette, MD, Rainer Richter, Manuel Afable, R.N., Jaroslaw P. Maciejewski, MD, PhD

Blood (2009) 114 (22): 1093.

https://doi.org/10.1182/blood.V114.22.1093.1093

Published: 2009

Journal Articles

Molecular Lesions Associated with Loss of Heterozygosity Identified in CMML.

Anna M. Jankowska, MSc, Hideki Makishima, MD, PhD, Rebecca D Ganetzky, B.A., Monika Jasek, PhD, Heather Cazzolli, Courtney Prince, B.S., Manuel Afable, R.N., Christine O'Keefe, PhD, Ramon V. Tiu, MD, Heesun J. Rogers, MD, PhD, Eric D. Hsi, MD, Mikkael A. Sekeres, MD, MS, Michael A McDevitt, Jaroslaw P. Maciejewski, MD, PhD

Blood (2009) 114 (22): 416.

https://doi.org/10.1182/blood.V114.22.416.416

Published: 2009

Journal Articles

Identification of Genetic Polymorphisms Contributing to Risk in MDS Using Innovative GWAS Approaches.

Sandra P Smieszek, Bartlomiej P Przychodzen, Ron Paquette, MD, Rainer Richter, Manuel Afable, R.N., Jaroslaw P. Maciejewski, MD, PhD

Blood (2009) 114 (22): 734.

https://doi.org/10.1182/blood.V114.22.734.734

Published: 2009

Journal Articles

Loss of heterozygosity 4q24 and TET2 mutations associated with myelodysplastic/myeloproliferative neoplasms

Anna M. Jankowska, Hadrian Szpurka, Ramon V. Tiu, Hideki Makishima, Manuel Afable, Jungwon Huh, Christine L. O'Keefe, Rebecca Ganetzky, Michael A. McDevitt, Jaroslaw P. Maciejewski

Blood (2009) 113 (25): 6403–6410.

https://doi.org/10.1182/blood-2009-02-205690

Published: 2009

NARROW

A Phase II Study of Curcumin and Vitamin D in Previously Untreated Patients with Early Stage Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL)

Phase I Trial of the Base – Excision Repair Blocker Methoxyamine (TRC-102) Combined with Fludarabine in Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) and Lymphoid Malignancies

Brentuximab Vedotin (BV) Does Not Impair Autologous Peripheral Blood Stem Cell Mobilization and Collection in Refractory/Relapsed CD30+ Lymphoma Patients Undergoing High-Dose Chemotherapy and Autologous Stem Cell Transplant (HDC-ASCT)

Molecular Defects In BRCC3 Complex, a Novel Pathogenic Pathway In MDS

STAT3 mutations indicate the presence of subclinical T-cell clones in a subset of aplastic anemia and myelodysplastic syndrome patients

Phase 2 study of the lenalidomide and azacitidine combination in patients with higher-risk myelodysplastic syndromes

STAT3 mutations unify the pathogenesis of chronic lymphoproliferative disorders of NK cells and T-cell large granular lymphocyte leukemia

Efficacy of Rabbit Anti-Thymocyte Globulin (ATG) Compared to Horse ATG In Severe Aplastic Anemia

Deletions of Xp22.2 Including PIG-A Locus Lead to Paroxysmal Nocturnal Hemoglobinuria.

Cytogenetic Predictors of Response to Lenalidomide In Myeloid Malignancies without Del(5q)

GWAS Indicates the Presence of Rare Immunogenetic Polymorphisms as Possible Predisposition Factors in Aplastic Anemia.

Molecular Lesions Associated with Loss of Heterozygosity Identified in CMML.

Identification of Genetic Polymorphisms Contributing to Risk in MDS Using Innovative GWAS Approaches.

Loss of heterozygosity 4q24 and TET2 mutations associated with myelodysplastic/myeloproliferative neoplasms

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only